Browse > Article

Expression of p53 and Ki-67 in Salivary Gland Tumors  

Min Hyun-Jung (Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Hanyang University)
Kim Kyung-Rae (Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Hanyang University)
Park Chul-Won (Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Hanyang University)
Lee Hyung-Seok (Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Hanyang University)
Paik Seung-Sam (Department of Pathology, College of Medicine, Hanyang University)
Oh Young-Ha (Department of Pathology, College of Medicine, Hanyang University)
Tae Kyung (Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Hanyang University)
Publication Information
Korean Journal of Head & Neck Oncology / v.22, no.1, 2006 , pp. 8-14 More about this Journal
Abstract
Objectives: The p53 tumor suppressor gene has a key role in cellular control mechanisms involving apoptosis and DNA repair, leading to the G1 arrest following DNA damage. Its mutation is one of the most frequent alterations in human cancers. Ki-67 is identified in replicating cells of both benign and malignant lesions, so it can be the predictor of proliferative activity. The aim of this study is to evaluate the expression of p53 and Ki-67 in salivary gland tumors. Materials and Methods: Immunohistochemical analysis was used to detect expression of p53 and Ki-67 in paraffin-embedded samples from 31 benign and 27 malignant salivary gland tumors. Results were analyzed between benign and malignant tumors and compared with the clinical parameters such as stage and recurrence in malignant tumors. Results: p53 overexpression was detected in 19.6% of benign tumors and 40.7% of malignant tumors, but there was no statistical significance. p53 was significantly expressed in Warthin's tumor(45.5%) compared with pleomorphic adenoma(5.9%). Only 5.9% of pleomorphic adenoma were positive for p53, while 60% of carcinoma ex pleomorphic adenoma were positive for p53. Ki-67 was expressed in 3.2% of benign tumors and 51.9% of malignant tumors, which showed significant higher expression in malignant tumors. In malignant tumors, p53 and Ki-67 expressions bore no correlation to stage and recurrence. Conclusion: p53 overexpression is not associated with the progression of malignant tumors, and Ki-67 overexpression can be used as biologic indicator of malignant salivary gland tumors.
Keywords
p53; Ki-67; Salivary gland neoplasms;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Soini Y, Kamel D, Nuorva K, Lane DP, Vahakangas K, Paakko P: Low p53 protein expression in salivary gland tumors compared with lung carcinomas. Virchows Archiv A Pathol Anat. 1992;421: 415-420   DOI
2 Brown DC, Gatter KC: Monoclonal antibody Ki-67: its use in histopathology. Histopathology. 1990;17:489-503   DOI
3 Pelosi G, Zamboni G: Proliferation markers and their uses in the study of endocrine tumors. Endocr Pathol. 1996;7:103-119   DOI
4 Milner J: A conformation hypothesis for the suppressor and promoter function of p53 in cell growth control and cancer. Proc Biol Sci. 1991;245:139-145
5 Alves FA, Pires FR, De Almeida OP, Lopes MA, Kowalski LP: PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours. Int J Oral Maxillofac Surg. 2004;33:593-597   DOI   ScienceOn
6 Bukholm IK, Nesland JM, Karesen R, Jacobsen U, Borresen AL: Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas. J Pathol. 1997;181: 140-145   DOI   ScienceOn
7 Welkoborsky HJ, Hinni M, Dienes HP, Mann WJ: Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol. 1995;104:503-510   DOI
8 Karja VJ, Syrjanen KJ, Kurvinen AK, Syrjanen SM: Expression and mutations of p53 in salivary gland tumours. J Oral Pathol Med. 1997;26:217-223   DOI   ScienceOn
9 Lazzaro B, Cleveland D: p53 and Ki67 antigen expression in small oral biopsy specimens of salivary gland tumors. Oral Surg Oral Pathol Oral Radiol Endod. 2000;89:613-617   DOI   ScienceOn
10 Nagao T, Sugano I, Ishida Y, et al: Basal cell adenocarcinoma of the salivary glands comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2. Cancer. 1998;82:439-447   DOI   ScienceOn
11 Field JK, Pavelic ZP, Spandidos DA, Stambrook PJ, Jones AS, Gluckman JL: The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1993;119:1118-1122   DOI   ScienceOn
12 Yoo YS, Seo M, Woo HY, Lee CH, Choi JH: Expression of p53, PCNA, EGFR in rat submandibular gland tumor induced experimentally. Korean J Otolaryngol. 2000;43:631-637
13 Cho JH, Suh BD, Jun BC, et a1: Detection of human papillomavirus and Epstein-Barr virus in sinonasal inverted papillomas and its correlation with p53 and proliferating cell nuclear antigen expression. Korean J Otolaryngol. 2000;43:836-843
14 Hellquist HB, Snndelin K, Di Bacco A, Tytor M, Manzotti M, Viale G: Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL). J Pathol. 1997; 181:323-329   DOI   ScienceOn
15 Kiyoshima T, Shima K, Kobayashi I, et al: Expression of p53 tumor expression gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol 2001;37:315-322   DOI   ScienceOn
16 Spandidos DA, Anderson ML: Oncogenes and onco-suppressor genes: their involvement in cancer. J Pathol. 1989;157:1-10   DOI
17 Lorz M, Meyer-Breiting E, Bettinger R: Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer. Eur Arch Otolaryngol. 1994;251 :91-94   DOI
18 Nordgard S, Franzen G, Boysen M, Halvorsen TB: Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIBI in paraffin sections. Laryngoscope. 1997;107:531-536   DOI   ScienceOn
19 Nordkvist A, Roijer E, Bang G, et al: Expression and mutation patterns of p53 in benign and malignant salivary gland tumors. Int J Oncol. 2000;16:477-483
20 Fracchiolla NS, Capaccio P, Carboni N, et al: Immunohistochemical and molecular analysis of bax, bcl-2 and p53 genes in laryngeal squamous cell carcinomas. Anticancer Res. 1999;19:1043-1051